|
valemetostat tosylate Clinical Trials
2 actively recruiting trials across 1 location
▼ -2 trials since July 2026
Also known as: DS-3201b, valemetostat
Pipeline
Phase 2: 2
Top Sponsors
- Gustave Roussy, Cancer Campus, Grand Paris1
- Alliance for Clinical Trials in Oncology1
Indications
- Cancer2
- Clear Cell Endometrial Carcinoma1
- Castration-Resistant Prostate Carcinoma1
- Solid Tumor Malignancies1
- Stage IVB Prostate Cancer AJCC v81
Other1 trial
Birmingham, Alabama1 trial
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
University of Alabama at Birmingham Cancer Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.